High-flying biotech Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) was called out for its rapid drug price raises today by Senator Bernie Sanders, and its stock quickly crashed as a result. Since the beginning of the year, the company …
Ariad Pharmaceuticals.Inc ARIA was a big mover last session, as the company saw its shares rise by over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses …
Additionally, ARIA received the most recent edition of Certification of ... other investments in the quarter included $9 million in CapEx and $36 million to repurchase shares of our stock. As of the end of the quarter, we had 4.4 million shares …
ARIA stock had traded over $20 a share in September, but ARIA stock plunged in October after the U.S. Food and Drug Administration halted a trial of its anti-cancer treatment, Iclusig, after some patients developed blood clots. The buyers …
The stock prices of both companies fell Wednesday after the tentative ... Takeda has previously acquired two other Massachusetts biotechs, Ariad Pharmaceuticals …
Takeda has offered the equivalent of 49 pounds in cash and stock for each share of Shire ... been expanding overseas to compensate for slowing growth at home. …
Major biotech stocks like Amgen AMGN and Gilead GILD reported fourth quarter results -- while both topped estimates, revenue outlook fell short of expectations. Recap of the Week’s Most Important Stories Amgen Delivers Strong Quarter …
One stock that might be an intriguing choice for investors right now is Ariad Pharmaceuticals Inc. ( ARIA). This is because this security in the Medical-Drugs is seeing solid earnings estimate revision activity, and is in great company from a …
Bump stock manufacturers under fire The Justice Department said ... (Madison Miller/Las Vegas Review-Journal Correspondent) Suspected Aria counterfeiter …
Shire’s stock price had fallen 45 percent in the 15 months before ... Early last …